{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:16:06Z","timestamp":1786947366782,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jpba.2023.115918","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T04:10:50Z","timestamp":1702440650000},"page":"115918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The first LC-MS\/MS stereoselective bioanalytical methods to quantitatively detect 9R- and 9S-hexahydrocannabinols and their metabolites in human blood, oral fluid and urine"],"prefix":"10.1016","volume":"240","author":[{"given":"Giorgi","family":"Kobidze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Sprega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omayema","family":"Taoussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Bambagiotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sofia","family":"Fede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annagiulia","family":"Di Trana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Busard\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasio","family":"Tini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bezhan","family":"Chankvetadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo Fabrizio Lo","family":"Faro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2023.115918_bib1","article-title":"Hexahydrocannabinol on the light cannabis market: the latest \"New\" entry","author":"Casati","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.jpba.2023.115918_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1126\/science.92.2380.115","article-title":"Marihuana","volume":"92","author":"Adams","year":"1940","journal-title":"Science"},{"key":"10.1016\/j.jpba.2023.115918_bib3","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1021\/ja01852a053","article-title":"Tetrahydrocannabinol homologs and analogs with marihuana activity, X","volume":"63","author":"Adams","year":"1941","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jpba.2023.115918_bib4","unstructured":"I. Ujv\u00e1ry M. Evans-Brown A. Gallegos G. Planchuelo J. de Morais R. Christie R. Jorge R. Sedefov. EMCDDA: Technical report Hexahydrocannabinol (HHC) and related substances, (2023). doi: 10.2810\/852912."},{"key":"10.1016\/j.jpba.2023.115918_bib5","unstructured":"Gazzetta Ufficiale, Update of the tables containing the indication of narcotic and psychotropic substances, referred to in Presidential Decree No. 309 of October 9, 1990, as amended and supplemented. Inclusion in Table I of the substances HHC, HHC acetate and HHC-P. https:\/\/www.gazzettaufficiale.it\/atto\/serie_generale\/caricaDettaglioAtto\/originario?atto.dataPubblicazioneGazzetta=2023\u201307-25&atto.codiceRedazionale=23A04164&elenco30giorni=true&fbclid=IwAR0d8pv68emAlSwx5PPesHph7DtpXGIfcfaIaSbHuNDnEcBWRZf4ws750Ag, 2023 (accessed 23 August 2023)."},{"key":"10.1016\/j.jpba.2023.115918_bib6","doi-asserted-by":"crossref","DOI":"10.2174\/1570159X21666230623104624","article-title":"Hexahydrocannabinol pharmacology, toxicology, and analysis: the first evidence for a recent new psychoactive substance","author":"Graziano","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpba.2023.115918_bib7","unstructured":"R. Adams, Improvements in the manufacture of polyhydro-dibenzopyran derivatives: Marihuana Active Compounds, United States Patent US2419937A, (1947) https:\/\/patentimages.storage.googleapis.com\/06\/d6\/2e\/d564de8f944c73\/US2419937.pdf, (accessed 27 July 2023)."},{"key":"10.1016\/j.jpba.2023.115918_bib8","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1021\/jo00193a051","article-title":"An efficient desilylation method for the generation of O quinone methides: application to the synthesis of (+)- and (-)-hexahydrocannabinol","volume":"49","author":"Marino","year":"1984","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.jpba.2023.115918_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/anie.198202212","article-title":"Stereo- and regioselective synthesis of enantiomerically pure (+)- and (\u2212)-hexahydrocannabinol by intramolecular cycloaddition","volume":"21","author":"Tietze","year":"1982","journal-title":"Angew. Chem. Int"},{"key":"10.1016\/j.jpba.2023.115918_bib10","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1016\/j.tetlet.2008.03.075","article-title":"Efficient one-pot synthetic approaches for cannabinoid analogues and their application to biologically interesting (\u2212)-hexahydrocannabinol and (+)- hexahydrocannabinol","volume":"49","author":"Lee","year":"2008","journal-title":"Tetrahedron Lett."},{"issue":"3","key":"10.1016\/j.jpba.2023.115918_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1039\/C39860000271","article-title":"A one-step highly stereocontrolled synthesis of (\u2013)- and (+)-hexahydrocannabinol and related compounds","author":"Casiraghi","year":"1986","journal-title":"J. Chem. Soc. Chem. Commun."},{"key":"10.1016\/j.jpba.2023.115918_bib12","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1246\/cl.1992.1237","article-title":"Generation and intramolecular cycloaddition of o-quinone methides in protic solvent. An efficient synthesis of (\u2212)-trans-hexahydrocannabinol","volume":"21","author":"Lu","year":"1992","journal-title":"Chem. Lett."},{"key":"10.1016\/j.jpba.2023.115918_bib13","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1021\/jm00127a038","article-title":"The importance of the orientation of the C9 substituent to cannabinoid activity","volume":"32","author":"Reggio","year":"1989","journal-title":"J. Med Chem."},{"key":"10.1016\/j.jpba.2023.115918_bib14","first-page":"1","article-title":"Synthesis and characterization of the diastereomers of HHC and H4CBD","volume":"18","author":"Collins","year":"2023","journal-title":"Nat. Prod. Comm."},{"key":"10.1016\/j.jpba.2023.115918_bib15","unstructured":"A.I. Stothard N.K. Layle M.J. Martin J. Liu J.R. Bassman J.B. Williams K.W. Hering Characterizationof Hexahydrocannabinol Diastereomers by NMR, HPLC, GCMS, and TLC\u2019, ScientificPoster. (2022). https:\/\/cdn2.caymanchem.com\/cdn\/cms\/caymanchem\/LiteratureCMS\/Characterization%20of%20HHC%20Diastereomers.pdf."},{"key":"10.1016\/j.jpba.2023.115918_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-38188-5","article-title":"Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC)","volume":"13","author":"Russo","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpba.2023.115918_bib17","unstructured":"K.M. Yang, Organization of Scientific Area Committees (OSAC) for Forensic Science Standard Practices for Method Development, https:\/\/www.nist.gov\/osac."},{"key":"10.1016\/j.jpba.2023.115918_bib18","doi-asserted-by":"crossref","unstructured":"J. Mandel, The statistical analysis of experimental data, Biom.J. 101 (968) 231\u2013279. https:\/\/doi.org\/10.1002\/bimj.19680100407.","DOI":"10.1002\/bimj.19680100407"},{"key":"10.1016\/j.jpba.2023.115918_bib19","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523006878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523006878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:36:07Z","timestamp":1760002567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523006878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":19,"alternative-id":["S0731708523006878"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115918","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The first LC-MS\/MS stereoselective bioanalytical methods to quantitatively detect 9R- and 9S-hexahydrocannabinols and their metabolites in human blood, oral fluid and urine","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115918"}}